Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193805-13-002068
Filing Date
2013-11-13
Accepted
2013-11-12 19:15:58
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 e611529_10q-retrophin.htm 10-Q 889977
2 e611529_ex31-1.htm EX-31.1 14987
3 e611529_ex31-2.htm EX-31.2 15042
4 e611529_ex32-1.htm EX-32.1 5725
5 e611529_ex32-2.htm EX-32.2 5779
  Complete submission text file 0001193805-13-002068.txt   3495201

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20130930.xml EX-101.INS 354507
7 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20130930.xsd EX-101.SCH 42186
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20130930_cal.xml EX-101.CAL 47368
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20130930_def.xml EX-101.DEF 60963
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20130930_lab.xml EX-101.LAB 214603
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20130930_pre.xml EX-101.PRE 155551
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 000-53293 | Film No.: 131211932
SIC: 2834 Pharmaceutical Preparations